Govt creating 'artificial scarcity' of shots to benefit Bharat Biotech, SII: AAP

India is currently using mainly two 'made-in India' jabs Covishield manufactured by the Serum Institute and Covaxin of Bharat Biotech and Russian-made Sputnik V at a smaller scale to inoculate its pop

Vials, Vaccine
Photo: Shutterstock
Press Trust of India New Delhi
2 min read Last Updated : May 28 2021 | 4:14 PM IST

The AAP on Friday alleged that the Centre is creating "artificial scarcity" of COVID-19 vaccines to benefit Bharat Biotech and Serum Institute of India, a charge termed by the Delhi BJP as "unfounded".

Addressing a press conference, AAP spokesperson Atishi said the government's vaccine drive has stopped in schools and this is the case throughout the country while in private hospitals, vaccination is still going on at different rates.

India is currently using mainly two 'made-in India' jabs Covishield manufactured by the Serum Institute and Covaxin of Bharat Biotech and Russian-made Sputnik V at a smaller scale to inoculate its population.

"This is big racket. At government centres where vaccination was given free to the youth, vaccines are in shortage there, while vaccinations are going on at higher prices at hospitals," she alleged.

She further questioned the Centre over not giving emergency approval to more vaccines.

"Many vaccines are being approved across the world. Pfizer vaccine has been approved in 85 countries, Moderna vaccine has been approved in 46 countries and J&J is approved in 41 countries.

"Then why these three vaccines were not given emergency authorisation. If WHO can approve them, why can't India? This clearly shows that the Centre has created this artificial scarcity to favour Serum Institute of India and Bharat Biotech," she alleged.

She further said these two companies do not have manufacturing capacity but the Centre has not approved more vaccines.

"The Centre created such an artificial scarcity that states have to buy from them only. The Centre should respond to this," she said.

Delhi BJP Spokesperson Praveen Shankar Kapoor said Atishi's allegation is unfounded as scarcity has not been created by the government.

Atishi should know that SII and Bharat Biotech don't stand to gain by the scarcity because scarcity means entry of foreign manufacturers.

Creating scarcity and putting general people at discomfort is the speciality of Delhi chief minister Arvind Kejriwal, he claimed.

"He spoke on hospital beds scarcity which forced people to pay hefty fees to private hospitals, he spoke of oxygen scarcity and we saw oxygen mafia loot, we saw black marketing of Covid medicines as he spoke of medicines shortage," Kapoor claimed.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: May 28 2021 | 4:07 PM IST

Next Story